|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Rheumatoid arthritis w rheumatoid factor w/o org/sys involv
ICD-10 (CM) Code and Descriptor
|
M05.7A |
Rheumatoid arthritis with rheumatoid factor of other specified site without organ or systems involvement
|
M057A utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 40.50%
|
17.83%
|
13.21%
|
10.56%
|
5.47%
|
4.61%
|
3.13%
|
1.56%
|
1.17%
|
0.78%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M05.7A*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
117
|
117
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
106
|
107
|
|
80053
|
COMPREHEN METABOLIC PANEL |
95
|
95
|
|
86140
|
C-REACTIVE PROTEIN |
87
|
87
|
|
97530
|
THERAPEUTIC ACTIVITIES |
81
|
118
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
76
|
76
|
|
85652
|
RBC SED RATE AUTOMATED |
76
|
76
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
46
|
71
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
38
|
38
|
|
97110
|
THERAPEUTIC EXERCISES |
34
|
61
|
|
97116
|
GAIT TRAINING THERAPY |
33
|
35
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
25
|
25
|
|
J0129
|
ABATACEPT INJECTION |
24
|
1,325
|
|
97035
|
APP MDLTY 1+ULTRASOUND EA 15 |
24
|
42
|
|
J3262
|
TOCILIZUMAB INJECTION |
21
|
4,560
|
|
86480
|
TB TEST CELL IMMUN MEASURE |
20
|
20
|
|
84443
|
ASSAY THYROID STIM HORMONE |
19
|
19
|
|
85651
|
RBC SED RATE NONAUTOMATED |
18
|
18
|
|
80076
|
HEPATIC FUNCTION PANEL |
17
|
17
|
|
J1602
|
GOLIMUMAB FOR IV USE 1MG |
17
|
2,100
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M05.7A related to the following DRG Codes:
545-547
|
